UBS Group
DRTS icon

UBS Group’s Alpha Tau Medical DRTS Stock Holding History

UBS Group’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Buy
286,688
+265,988
+1,285% +$1.88M ﹤0.01% 4969
2025
Q4 		$102K Sell
20,700
-9,919
-32% -$41.8K ﹤0.01% 6900
2025
Q3 		$138K Sell
30,619
-2,700
-8% -$9.19K ﹤0.01% 6900
2025
Q2 		$104K Buy
33,319
+300
+0.9% +$845 ﹤0.01% 7209
2025
Q1 		$82.9K Buy
33,019
+32,949
+47,070% +$103K ﹤0.01% 7191
2024
Q4 		$217 Sell
70
-1,109
-94% -$2.84K ﹤0.01% 9561
2024
Q3 		$2.81K Buy
+1,179
New +$2.61K ﹤0.01% 8363
2024
Q2 		– Sell
-37
Closed -$109 – 9635
2024
Q1 		$109 Buy
+37
New +$114 ﹤0.01% 8830
2023
Q2 		– Sell
-1,292
Closed -$3.71K – 9056
2023
Q1 		$3.71K Sell
1,292
-254
-16% -$886 ﹤0.01% 8287
2022
Q4 		$4.92K Buy
+1,546
New +$6.4K ﹤0.01% 9249
2022
Q3 		– Sell
-1,916
Closed -$17K – 10454
2022
Q2 		$17K Buy
1,916
+1,016
+113% +$9.1K ﹤0.01% 7086
2022
Q1 		$11K Buy
+900
New +$10.6K ﹤0.01% 8291

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group's DRTS Position: Q1 2026 in Review

UBS Group increased its Alpha Tau Medical (DRTS) stake by 1,285% in Q1 2026, buying an estimated $1.88M and bringing the position to 286,688 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #4969.

UBS Group first reported a position in DRTS in Q1 2022 and has held it in 12 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • UBS Group held 286,688 shares of Alpha Tau Medical worth $2.03M as of Q1 2026.
  • UBS Group bought 265,988 Alpha Tau Medical shares in Q1 2026, an estimated $1.88M.
  • Alpha Tau Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4969 holding.
  • UBS Group first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 12 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.